Safety of pre- or postoperative accelerated radiotherapy in 5 fractions: A randomized pilot trial

Cardoso, 2019, Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 30, 1194, 10.1093/annonc/mdz173 Masuda, 2017, Adjuvant capecitabine for breast cancer after preoperative chemotherapy, N Engl J Med, 376, 2147, 10.1056/NEJMoa1612645 von Minckwitz, 2019, Trastuzumab emtansine for residual invasive HER2-positive breast cancer, N Engl J Med, 380, 617, 10.1056/NEJMoa1814017 Asselain, 2018, Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials, Lancet Oncol, 19, 27, 10.1016/S1470-2045(17)30777-5 Pierquin, 1991, Conservative treatment for breast cancer: long-term results (15 years), Radiother Oncol, 20, 16, 10.1016/0167-8140(91)90107-R Roth, 2010, Retrospective study of neoadjuvant versus adjuvant radiochemotherapy in locally advanced noninflammatory breast cancer: survival advantage in cT2 category by neoadjuvant radiochemotherapy, Strahlenther Onkol, 186, 299, 10.1007/s00066-010-2143-0 Lerouge, 2004, Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients, Int J Radiat Oncol Biol Phys, 59, 1062, 10.1016/j.ijrobp.2003.12.034 Shanta, 2008, Retrospective analysis of locally advanced noninflammatory breast cancer from Chennai, South India, 1990-1999, Int J Radiat Oncol Biol Phys, 70, 51, 10.1016/j.ijrobp.2007.05.050 Calitchi, 1991, External irradiation prior to conservative surgery for breast cancer treatment, Int J Radiat Oncol, 21, 325, 10.1016/0360-3016(91)90778-3 Murray Brunt, 2020, Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial, Lancet, 395, 1613, 10.1016/S0140-6736(20)30932-6 Brunt, 2020, Ten-year results of fast: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer, J Clin Oncol, 38, 3261, 10.1200/JCO.19.02750 Van Hulle, 2021, Acute toxicity and health-related quality of life after accelerated whole breast irradiation in 5 fractions with simultaneous integrated boost, Breast, 55, 105, 10.1016/j.breast.2020.12.009 Van Hulle, 2019, Accelerating adjuvant breast irradiation in women over 65 years: matched case analysis comparing a 5-fractions schedule with 15 fractions in early and locally advanced breast cancer, J Geriatr Oncol, 10 Van Hulle, 2020, Health-related quality of life after accelerated breast irradiation in five fractions: a comparison with fifteen fractions, Radiother Oncol, 151, 47, 10.1016/j.radonc.2020.07.007 Hörner-Rieber, 2020, Intensity modulated radiation therapy (IMRT) with simultaneously integrated boost shortens treatment time and is noninferior to conventional radiation therapy followed by sequential boost in adjuvant breast cancer treatment: results of a large randomized, Int J Radiat Oncol Paelinck, 2017, Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial, Radiother Oncol, 122, 30, 10.1016/j.radonc.2016.12.023 Van Hulle, 2021, Two-year toxicity of simultaneous integrated boost in hypofractionated prone breast cancer irradiation: comparison with sequential boost in a randomized trial, Radiother Oncol, 158, 62, 10.1016/j.radonc.2021.02.010 Bleicher, 2016, Time to surgery and breast cancer survival in the United States, JAMA Oncol, 2, 330, 10.1001/jamaoncol.2015.4508 Khorana, 2019, Time to initial cancer treatment in the United States and association with survival over time: an observational study, PLoS One, 14, 1 Kupstas, 2019, Effect of surgery type on time to adjuvant chemotherapy and impact of delay on breast cancer survival: a national cancer database analysis, Ann Surg Oncol, 26, 3240, 10.1245/s10434-019-07566-7 Suleman, 2020, Does the timing of surgery after neoadjuvant therapy in breast cancer patients affect the outcome?, Oncol, 98, 168, 10.1159/000504964 Omarini, 2017, Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients, Eur J Surg Oncol, 43, 613, 10.1016/j.ejso.2016.09.020 Silva, 2018, Clinical impact of adjuvant radiation therapy delay after neoadjuvant chemotherapy in locally advanced breast cancer, Breast, 38, 39, 10.1016/j.breast.2017.11.012 Richards, 1999, Influence of delay on survival in patients with breast cancer: a systematic review, Lancet, 353, 1119, 10.1016/S0140-6736(99)02143-1 Morante, 2020, Impact of the delayed initiation of adjuvant chemotherapy in the outcome of triple negative breast cancer, Clin Breast Cancer Wayne, 1957, A clinical comparison of the symptoms of hypoxia and hyperventilation, Proj Rep Issue, 106–154 Mateo, 2020, Time to surgery and the impact of delay in the non-neoadjuvant setting on triple-negative breast cancers and other phenotypes, Ann Surg Oncol, 27, 1679, 10.1245/s10434-019-08050-y Van Hulle, 2020, Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients, Pilot Feasibility Stud, 6, 4, 10.1186/s40814-020-00693-z Verhoeven, 2015, Vessel based delineation guidelines for the elective lymph node regions in breast cancer radiation therapy - PROCAB guidelines, Radiother Oncol, 114, 11, 10.1016/j.radonc.2014.11.008 Van Hulle, 2020, Two-year toxicity of hypofractionated breast cancer radiotherapy in five fractions, Acta Oncol (Madr), 59, 872, 10.1080/0284186X.2020.1747638 Bollet, 2012, Preoperative radio-chemotherapy in early breast cancer patients: long-term results of a phase II trial, Radiother Oncol, 102, 82, 10.1016/j.radonc.2011.08.017 Formenti, 2003, Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial, J Clin Oncol, 21, 864, 10.1200/JCO.2003.06.132 Alvarado-Miranda, 2009, Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer, Radiat Oncol, 4, 1, 10.1186/1748-717X-4-24 Matuschek, 2019, Long-term cosmetic outcome after preoperative radio-/chemotherapy in locally advanced breast cancer patients, Strahlenther Onkol, 195, 615, 10.1007/s00066-019-01473-2 Brackstone, 2017, Concurrent neoadjuvant chemotherapy and radiation therapy in locally advanced breast cancer, Int J Radiat Oncol Biol Phys, 99, 769, 10.1016/j.ijrobp.2017.06.005 Toledano, 2007, Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial, J Clin Oncol, 25, 405, 10.1200/JCO.2006.07.8576 Toledano, 2006, Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study, Int J Radiat Oncol Biol Phys, 65, 324, 10.1016/j.ijrobp.2005.12.020 Poleszczuk J, Luddy K, Chen L, Lee JK, Harrison LB, Czerniecki BJ, et al. Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival n.d. https://doi.org/10.1186/s13058-017-0870-1. Daveau, 2011, Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?, Int J Radiat Oncol Biol Phys, 79, 1452, 10.1016/j.ijrobp.2010.01.003 Touboul, 1996, Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer, Int J Radiat Oncol Biol Phys, 34, 1019, 10.1016/0360-3016(95)02207-4 Semiglazov, 1994, Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer, Ann Oncol, 5, 591, 10.1093/oxfordjournals.annonc.a058929 Cortazar, 2014, Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis, Lancet, 384, 164, 10.1016/S0140-6736(13)62422-8 Lightowlers, 2017, Preoperative breast radiation therapy: indications and perspectives, Eur J Cancer, 82, 184, 10.1016/j.ejca.2017.06.014 Nichols, 2010, Comparative analysis of the post-lumpectomy target volume versus the use of pre-lumpectomy tumor volume for early-stage breast cancer: implications for the future, Int J Radiat Oncol Biol Phys, 10.1016/j.ijrobp.2009.04.063 O'Sullivan, 2002, Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial, Lancet, 359, 2235, 10.1016/S0140-6736(02)09292-9 Glimelius, 2003, A systematic overview of radiation therapy effects in rectal cancer, Acta Oncol (Madr), 42, 476, 10.1080/02841860310012301 Abe, 2005, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet, 366, 2087, 10.1016/S0140-6736(05)67887-7 Sauer, 2012, Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years, J Clin Oncol, 30, 1926, 10.1200/JCO.2011.40.1836 Demaria, 2015, Role of local radiation therapy in cancer immunotherapy, JAMA Oncol, 1, 1325, 10.1001/jamaoncol.2015.2756 Halvaei, 2018, Exosomes in cancer liquid biopsy: a focus on breast cancer, Mol Ther Nucleic Acids, 10, 131, 10.1016/j.omtn.2017.11.014 Hickey, 2013, Sequencing of chemotherapy and radiotherapy for early breast cancer, Cochrane Database Syst Rev, 2013 Franzoi, 2021, Immunotherapy for early breast cancer: too soon, too superficial, or just right?, Ann Oncol, 32, 323, 10.1016/j.annonc.2020.11.022